Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5646)
All Articles published online
|
Publishing Process of This Article
|
Jan 21, 2023 (publication date) through Apr 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jeeyavudeen MS, Chaudhari R, Pappachan JM, Fouda S. Clinical implications of COVID-19 in patients with metabolic-associated fatty liver disease. World J Gastroenterol 2023; 29(3): 487-502 [PMID: 36688018 DOI: 10.3748/wjg.v29.i3.487] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i3/487.htm |
| Number | Citing Articles |
| 1 |
Yuliya Kupriyanova, Iryna Yurchenko, Pavel Bobrov, Frederik Bartels, Stefan Wierichs, Marc Jonuscheit, Benedict Korzekwa, Katsiaryna Prystupa, Martin Schön, Dania Mendez, Sandra Trenkamp, Volker Burkart, Robert Wagner, Vera Schrauwen-Hinderling, Michael Roden. Alterations of hepatic lipid content following COVID-19 in persons with type 2 diabetes. BMJ Open Diabetes Research & Care 2025; 13(1): e004727 doi: 10.1136/bmjdrc-2024-004727
|
| 2 |
Cansu Memiç‐İnan, Mustafa Çapraz, Aylin Çapraz. Association of blood lipids with mortality in COVID‐19 patients. Lipids 2025; doi: 10.1002/lipd.12437
|
| 3 |
Thomas Grewal, Christa Buechler. Adipokines as Diagnostic and Prognostic Markers for the Severity of COVID-19. Biomedicines 2023; 11(5): 1302 doi: 10.3390/biomedicines11051302
|
| 4 |
Mandal Avishek. Prospective Coronavirus Liver Effects: Available Knowledge. Annals of Clinical Gastroenterology and Hepatology 2023; 7(1): 001 doi: 10.29328/journal.acgh.1001039
|
| 5 |
Pan Yan, Xiaoping Yu, Zhu Chen, Lijuan Lan, Jun Kang, Bennan Zhao, Dafeng Liu. Assessing the consistency of FIB-4, APRI, and GPR in evaluating significant liver fibrosis and cirrhosis in COVID-19 patients with concurrent liver diseases. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-03770-w
|
| 6 |
Caterina Conte, Elisa Cipponeri, Michael Roden. Diabetes Mellitus, Energy Metabolism, and COVID-19. Endocrine Reviews 2024; 45(2): 281 doi: 10.1210/endrev/bnad032
|
| 7 |
Leonidas Brilakis, Eirini Theofilogiannakou, Panagis M Lykoudis. Current remarks and future directions on the interactions between metabolic dysfunction-associated fatty liver disease and COVID-19. World Journal of Gastroenterology 2024; 30(11): 1480-1487 doi: 10.3748/wjg.v30.i11.1480
|